| Species |
hsa |
hsa |
mmu |
rno |
gga |
mcc |
mcc |
cfa |
fca |
| Symbol |
KLRD1 |
KLRC1 |
Klrc1 |
Klrd1 |
LOC769174 |
KLRD1 |
KLRC3 |
KLRD1 |
KLRD1 |
| Function* |
killer cell lectin like receptor D1 |
killer cell lectin like receptor C1 |
killer cell lectin-like receptor subfamily C, member 1 |
killer cell lectin like receptor D1 |
C-type lectin-like receptor variant |
killer cell lectin like receptor D1 |
killer cell lectin-like receptor subfamily C, member 3 |
killer cell lectin like receptor D1 |
killer cell lectin like receptor D1 |
| Expression |
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
| Umap |
|
|
|
|
|
|
|
|
|
| Coexpression |
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| hsa04650 |
Natural killer cell mediated cytotoxicity |
9 |
|
| hsa05332 |
Graft-versus-host disease |
5 |
|
| hsa04210 |
Apoptosis |
4 |
|
| hsa04612 |
Antigen processing and presentation |
4 |
|
| hsa04940 |
Type I diabetes mellitus |
3 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| hsa04650 |
Natural killer cell mediated cytotoxicity |
7 |
|
| hsa04612 |
Antigen processing and presentation |
4 |
|
| hsa04060 |
Cytokine-cytokine receptor interaction |
3 |
|
| hsa05332 |
Graft-versus-host disease |
3 |
|
| hsa04061 |
Viral protein interaction with cytokine and cytokine receptor |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| mmu04650 |
Natural killer cell mediated cytotoxicity |
8 |
|
| mmu05332 |
Graft-versus-host disease |
6 |
|
| mmu04060 |
Cytokine-cytokine receptor interaction |
5 |
|
| mmu05144 |
Malaria |
4 |
|
| mmu04940 |
Type I diabetes mellitus |
4 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| rno04650 |
Natural killer cell mediated cytotoxicity |
4 |
|
| rno05332 |
Graft-versus-host disease |
3 |
|
| rno04658 |
Th1 and Th2 cell differentiation |
3 |
|
| rno04659 |
Th17 cell differentiation |
3 |
|
| rno04060 |
Cytokine-cytokine receptor interaction |
3 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| gga04512 |
ECM-receptor interaction |
4 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| mcc04650 |
Natural killer cell mediated cytotoxicity |
4 |
|
| mcc04612 |
Antigen processing and presentation |
4 |
|
| mcc05332 |
Graft-versus-host disease |
3 |
|
| mcc04020 |
Calcium signaling pathway |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| mcc04650 |
Natural killer cell mediated cytotoxicity |
6 |
|
| mcc04612 |
Antigen processing and presentation |
4 |
|
| mcc05332 |
Graft-versus-host disease |
3 |
|
| mcc05206 |
MicroRNAs in cancer |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| cfa04650 |
Natural killer cell mediated cytotoxicity |
5 |
|
| cfa05332 |
Graft-versus-host disease |
4 |
|
| cfa04060 |
Cytokine-cytokine receptor interaction |
4 |
|
| cfa04612 |
Antigen processing and presentation |
3 |
|
| cfa04210 |
Apoptosis |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map (Multiple genes) |
| fca04650 |
Natural killer cell mediated cytotoxicity |
5 |
|
| fca04060 |
Cytokine-cytokine receptor interaction |
3 |
|
| fca05332 |
Graft-versus-host disease |
2 |
|
| fca04061 |
Viral protein interaction with cytokine and cytokine receptor |
2 |
|
| fca04062 |
Chemokine signaling pathway |
2 |
|
|
| GO BP* |
|
GO:0002228 [L] [N] natural killer cell mediated immunity
|
(2 genes)
|
|
GO:0001915 [L] [N] negative regulation of T cell mediated cytotoxicity
|
(8 genes)
|
|
GO:0045953 [L] [N] negative regulation of natural killer cell mediated cytotoxicity
|
(12 genes)
|
|
GO:0045954 [L] [N] positive regulation of natural killer cell mediated cytotoxicity
|
(24 genes)
|
|
GO:0002223 [L] [N] stimulatory C-type lectin receptor signaling pathway
|
(115 genes)
|
|
GO:0050776 [L] [N] regulation of immune response
|
(208 genes)
|
|
GO:0007166 [L] [N] cell surface receptor signaling pathway
|
(283 genes)
|
|
GO:0002250 [L] [N] adaptive immune response
|
(397 genes)
|
|
GO:0045087 [L] [N] innate immune response
|
(554 genes)
|
|
|
GO:0002305 [L] [N] CD8-positive, gamma-delta intraepithelial T cell differentiation
|
(3 genes)
|
|
GO:0002769 [L] [N] natural killer cell inhibitory signaling pathway
|
(3 genes)
|
|
GO:0001915 [L] [N] negative regulation of T cell mediated cytotoxicity
|
(8 genes)
|
|
GO:0045953 [L] [N] negative regulation of natural killer cell mediated cytotoxicity
|
(12 genes)
|
|
GO:0050776 [L] [N] regulation of immune response
|
(208 genes)
|
|
GO:0007166 [L] [N] cell surface receptor signaling pathway
|
(283 genes)
|
|
GO:0002250 [L] [N] adaptive immune response
|
(397 genes)
|
|
GO:0045087 [L] [N] innate immune response
|
(554 genes)
|
|
|
GO:0002228 [L] [N] natural killer cell mediated immunity
|
(4 genes)
|
|
GO:0043323 [L] [N] positive regulation of natural killer cell degranulation
|
(6 genes)
|
|
GO:0002223 [L] [N] stimulatory C-type lectin receptor signaling pathway
|
(7 genes)
|
|
GO:0045954 [L] [N] positive regulation of natural killer cell mediated cytotoxicity
|
(30 genes)
|
|
|
GO:0002228 [L] [N] natural killer cell mediated immunity
|
(2 genes)
|
|
GO:0002223 [L] [N] stimulatory C-type lectin receptor signaling pathway
|
(5 genes)
|
|
GO:0001915 [L] [N] negative regulation of T cell mediated cytotoxicity
|
(6 genes)
|
|
GO:0045953 [L] [N] negative regulation of natural killer cell mediated cytotoxicity
|
(13 genes)
|
|
GO:0045954 [L] [N] positive regulation of natural killer cell mediated cytotoxicity
|
(31 genes)
|
|
GO:0002250 [L] [N] adaptive immune response
|
(104 genes)
|
|
|
|
|
|
GO:0001915 [L] [N] negative regulation of T cell mediated cytotoxicity
|
(1 genes)
|
|
GO:0002223 [L] [N] stimulatory C-type lectin receptor signaling pathway
|
(1 genes)
|
|
GO:0002228 [L] [N] natural killer cell mediated immunity
|
(1 genes)
|
|
GO:0045953 [L] [N] negative regulation of natural killer cell mediated cytotoxicity
|
(1 genes)
|
|
GO:0045954 [L] [N] positive regulation of natural killer cell mediated cytotoxicity
|
(1 genes)
|
|
GO:0002250 [L] [N] adaptive immune response
|
(12 genes)
|
|
|
| GO CC* |
|
GO:0043235 [L] [N] receptor complex
|
(209 genes)
|
|
GO:0005887 [L] [N] integral component of plasma membrane
|
(1413 genes)
|
|
GO:0005886 [L] [N] plasma membrane
|
(4709 genes)
|
|
|
GO:0043235 [L] [N] receptor complex
|
(209 genes)
|
|
GO:0005887 [L] [N] integral component of plasma membrane
|
(1413 genes)
|
|
GO:0005886 [L] [N] plasma membrane
|
(4709 genes)
|
|
|
GO:0043235 [L] [N] receptor complex
|
(220 genes)
|
|
GO:0009897 [L] [N] external side of plasma membrane
|
(590 genes)
|
|
GO:0005887 [L] [N] integral component of plasma membrane
|
(1271 genes)
|
|
|
GO:0043235 [L] [N] receptor complex
|
(216 genes)
|
|
GO:0009897 [L] [N] external side of plasma membrane
|
(392 genes)
|
|
GO:0005887 [L] [N] integral component of plasma membrane
|
(994 genes)
|
|
|
|
|
|
GO:0043235 [L] [N] receptor complex
|
(4 genes)
|
|
GO:0005887 [L] [N] integral component of plasma membrane
|
(31 genes)
|
|
|
| GO MF* |
|
GO:0023030 [L] [N] MHC class Ib protein binding, via antigen binding groove
|
(2 genes)
|
|
GO:0062082 [L] [N] HLA-E specific inhibitory MHC class Ib receptor activity
|
(2 genes)
|
|
GO:0023024 [L] [N] MHC class I protein complex binding
|
(6 genes)
|
|
GO:1990405 [L] [N] protein antigen binding
|
(8 genes)
|
|
GO:0004888 [L] [N] transmembrane signaling receptor activity
|
(160 genes)
|
|
GO:0030246 [L] [N] carbohydrate binding
|
(175 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(12443 genes)
|
|
|
GO:0062082 [L] [N] HLA-E specific inhibitory MHC class Ib receptor activity
|
(2 genes)
|
|
GO:0023024 [L] [N] MHC class I protein complex binding
|
(6 genes)
|
|
GO:1990405 [L] [N] protein antigen binding
|
(8 genes)
|
|
GO:0004888 [L] [N] transmembrane signaling receptor activity
|
(160 genes)
|
|
GO:0030246 [L] [N] carbohydrate binding
|
(175 genes)
|
|
GO:0005515 [L] [N] protein binding
|
(12443 genes)
|
|
|
GO:0062081 [L] [N] activating MHC class Ib receptor activity
|
(3 genes)
|
|
GO:0062082 [L] [N] HLA-E specific inhibitory MHC class Ib receptor activity
|
(3 genes)
|
|
GO:0023024 [L] [N] MHC class I protein complex binding
|
(7 genes)
|
|
GO:1990405 [L] [N] protein antigen binding
|
(13 genes)
|
|
|
GO:0023030 [L] [N] MHC class Ib protein binding, via antigen binding groove
|
(2 genes)
|
|
GO:0062082 [L] [N] HLA-E specific inhibitory MHC class Ib receptor activity
|
(2 genes)
|
|
GO:0023024 [L] [N] MHC class I protein complex binding
|
(6 genes)
|
|
GO:1990405 [L] [N] protein antigen binding
|
(13 genes)
|
|
GO:0030246 [L] [N] carbohydrate binding
|
(167 genes)
|
|
|
|
|
|
GO:0023024 [L] [N] MHC class I protein complex binding
|
(1 genes)
|
|
GO:0023030 [L] [N] MHC class Ib protein binding, via antigen binding groove
|
(1 genes)
|
|
GO:0062082 [L] [N] HLA-E specific inhibitory MHC class Ib receptor activity
|
(1 genes)
|
|
GO:1990405 [L] [N] protein antigen binding
|
(1 genes)
|
|
GO:0030246 [L] [N] carbohydrate binding
|
(8 genes)
|
|
|
| KEGG* |
| 04612 |
Antigen processing and presentation |
 |
| 04650 |
Natural killer cell mediated cytotoxicity |
 |
| 05332 |
Graft-versus-host disease |
 |
|
| 04612 |
Antigen processing and presentation |
 |
| 04650 |
Natural killer cell mediated cytotoxicity |
 |
| 05332 |
Graft-versus-host disease |
 |
|
| 04612 |
Antigen processing and presentation |
 |
| 04650 |
Natural killer cell mediated cytotoxicity |
 |
| 05332 |
Graft-versus-host disease |
 |
|
| 04612 |
Antigen processing and presentation |
 |
| 04650 |
Natural killer cell mediated cytotoxicity |
 |
| 05332 |
Graft-versus-host disease |
 |
|
|
| 04612 |
Antigen processing and presentation |
 |
| 04650 |
Natural killer cell mediated cytotoxicity |
 |
| 05332 |
Graft-versus-host disease |
 |
|
|
| 04612 |
Antigen processing and presentation |
 |
| 04650 |
Natural killer cell mediated cytotoxicity |
 |
| 05332 |
Graft-versus-host disease |
 |
|
| 04612 |
Antigen processing and presentation |
 |
| 04650 |
Natural killer cell mediated cytotoxicity |
 |
| 05332 |
Graft-versus-host disease |
 |
|
| Entrez Gene ID* |
3824 |
3821 |
16641 |
25110 |
769174 |
574145 |
696590 |
611360 |
101086731 |